Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Classic hallucinogens in the treatment of addictions
Michael P. Bogenschutz, Matthew W. Johnson
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015) Vol. 64, pp. 250-258
Closed Access | Times Cited: 204

Showing 26-50 of 204 citing articles:

Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions
Albert Garcia‐Romeu, William A. Richards
International Review of Psychiatry (2018) Vol. 30, Iss. 4, pp. 291-316
Closed Access | Times Cited: 153
Developing Guidelines and Competencies for the Training of Psychedelic Therapists
Janis Phelps
Journal of Humanistic Psychology (2017) Vol. 57, Iss. 5, pp. 450-487
Closed Access | Times Cited: 148
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials
Juan José Fuentes, Francina Fonseca, Matilde Elices, et al.
Frontiers in Psychiatry (2020) Vol. 10
Open Access | Times Cited: 137
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey
Albert Garcia‐Romeu, Alan K. Davis, Earth Erowid, et al.
Frontiers in Psychiatry (2020) Vol. 10
Open Access | Times Cited: 113
The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging
Rafael G. dos Santos, Fermanda M Balthazar, José Carlos Bouso, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 12, pp. 1230-1247
Closed Access | Times Cited: 112
Pivotal mental states
Ari Brouwer, Robin Carhart‐Harris
Journal of Psychopharmacology (2020) Vol. 35, Iss. 4, pp. 319-352
Open Access | Times Cited: 112
Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review
Simon Reiche, Leo Hermle, Stefan Gutwinski, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 81, pp. 1-10
Closed Access | Times Cited: 110
Epidemiology of hallucinogen use in the U.S. results from the National epidemiologic survey on alcohol and related conditions III
Nadav Shalit, Jürgen Rehm, Shaul Lev‐Ran
Addictive Behaviors (2018) Vol. 89, pp. 35-43
Closed Access | Times Cited: 108
A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses
Tingying Chi, Jessica A. Gold
Journal of the Neurological Sciences (2020) Vol. 411, pp. 116715-116715
Open Access | Times Cited: 76
Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism
Marcus W. Meinhardt, Simone Pfarr, Grégory Fouquet, et al.
Science Advances (2021) Vol. 7, Iss. 47
Open Access | Times Cited: 71
Substance-Induced Psychoses: An Updated Literature Review
A. Fiorentini, Filippo Cantù, Camilla Crisanti, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 69
Mescaline: The forgotten psychedelic
Ioanna A. Vamvakopoulou, Kelly A.D. Narine, Ian Campbell, et al.
Neuropharmacology (2022) Vol. 222, pp. 109294-109294
Open Access | Times Cited: 65
LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1
Ramona M. Rodriguiz, Vineet Nadkarni, Christopher R. Means, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 60
Trips and neurotransmitters: Discovering principled patterns across 6850 hallucinogenic experiences
Galen Ballentine, Samuel Friedman, Danilo Bzdok
Science Advances (2022) Vol. 8, Iss. 11
Open Access | Times Cited: 52
MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults
Grant Jones, Matthew K. Nock
Journal of Psychopharmacology (2022) Vol. 36, Iss. 1, pp. 46-56
Closed Access | Times Cited: 47
Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption
Emma Morton, Kimberly Sakai, Amir Ashtari, et al.
Journal of Psychopharmacology (2022) Vol. 37, Iss. 1, pp. 49-60
Open Access | Times Cited: 45
Mini-review: The neurobiology of treating substance use disorders with classical psychedelics
Marvin M. Urban, Moritz R. Stingl, Marcus W. Meinhardt
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 40
The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology
Andrea Mastinu, Margrate Anyanwu, Marinella Carone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1329-1329
Open Access | Times Cited: 36
Sex-specific effects of psychedelic drug exposure on central amygdala reactivity and behavioral responding
D. P. Effinger, Sema G. Quadir, M. C. Ramage, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Opioid use disorder: current trends and potential treatments
Yu Kyung Lee, Mark S. Gold, Kenneth Blum, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 14
Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions
Ricardo Jorge Dinis‐Oliveira, Carolina Lança Pereira, Diana Dias da Silva
Current Molecular Pharmacology (2018) Vol. 12, Iss. 3, pp. 184-194
Open Access | Times Cited: 81
Therapeutic Applications of Classic Hallucinogens
Michael P. Bogenschutz, Stephen Ross
Current topics in behavioral neurosciences (2016), pp. 361-391
Open Access | Times Cited: 74
LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm
Christopher Timmermann, Meg J. Spriggs, Mendel Kaelen, et al.
Neuropharmacology (2017) Vol. 142, pp. 251-262
Closed Access | Times Cited: 67
Psychedelics and music: neuroscience and therapeutic implications
Frederick S. Barrett, Katrin H. Preller, Mendel Kaelen
International Review of Psychiatry (2018) Vol. 30, Iss. 4, pp. 350-362
Closed Access | Times Cited: 61
The iboga enigma: the chemistry and neuropharmacology of iboga alkaloids and related analogs
Rishab N. Iyer, David Favela, Guoliang Zhang, et al.
Natural Product Reports (2020) Vol. 38, Iss. 2, pp. 307-329
Open Access | Times Cited: 57

Scroll to top